The Pharma Data

OCTOBER 28, 2020

REGN-COV2 significantly reduced viral load and patient medical visits (hospitalizations, emergency room, urgent care visits and/or physician office/telemedicine visits). The Phase 3 portion of this trial continues in non-hospitalized patients. combined dose groups; 6.5% placebo; p=0.024).

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

NOVEMBER 5, 2020

FDA accepted for priority review Libtayo ® (cemiplimab-rwlc) for both advanced non-small cell lung cancer and basal cell carcinoma. FDA approved Inmazeb for Ebola ( Zaire ebolavirus). REGN-COV2 , a dual antibody therapy to SARS-CoV-2 virus. Regeneron Pharmaceuticals, Inc. Schleifer , M.D.,

Production 52

Production FDA FDA Approval Trials 52

The Pharma Data

AUGUST 3, 2021

BLINCYTO ® (blinatumomab), our BiTE ® immunotherapy, sales increased 16% year-over-year for the second quarter, driven by 18% volume growth as we benefited from broader adoption in the community hospital setting. LUMAKRAS received accelerated approval based on overall response rate and duration of response. In the U.S., Bemarituzumab.

Biosimilars 52

Biosimilars Production Treatment FDA 52

The Pharma Data

NOVEMBER 21, 2020

NASDAQ: REGN) today announced that the antibody cocktail casirivimab and imdevimab administered together (also known as REGN-COV2 or REGEN-COV2), a therapy currently being investigated for use in COVID-19, has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). Regeneron Pharmaceuticals, Inc.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

JUNE 18, 2021

“Combining our novel therapies to deliver a new potential treatment is an example of AbbVie’s innovative approach to identify options for difficult-to-treat blood cancers, like CLL,” said Mohamed Zaki , M.D., IMBRUVICA is the only FDA-approved medicine in WM and cGVHD.

Treatment 40

Treatment FDA FDA Approval Therapies 40

The Pharma Data

JUNE 18, 2021

Time to subsequent therapy was longer for I+V (HR 0.143, 95% CI 0.05-0.41). “We are encouraged by these results, which further support the efficacy of these two well-established therapies,” said Mohamed Zaki, M.D., IMBRUVICA is the only FDA-approved medicine in WM and cGVHD.

Treatment 52

Treatment Therapies FDA FDA Approval 52

The Pharma Data

MAY 13, 2021

In this special report, I’m going to show you why researchers at Harvard University and the Massachusetts General Hospital in Boston are now praising a strange new pain treatment originally discovered on the International Space Station. But what actually is “Red Light Therapy”? You see, Red Light Therapy is expensive.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

MAY 5, 2021

FDA approves 100th monoclonal antibody product ( Nature Reviews Drug Discovery ). Affinia Therapeutics raises $110 million for gene therapy treatments ( STAT ). Pfizer’s Hospira recalls hospital anesthetics, flags ‘moderate to high severity’ safety risks ( Fierce ).

Vaccine 52

Vaccine FDA FDA Approval International 52